Patricia Novo
Datos Biográficos
| ID | 6073568 |
|---|---|
| NOMBRE | Patricia Novo |
| NOMBRES | Patricia |
| APELLIDO | Novo |
| FIRMA | NOVO P |
| AFILIACIONES | Steven Kritz and Lawrence S. Brown, Jr are with the Division of Medical Services, Research and Information Technology, Addiction Research and Treatment Corporation, New York, NY. Lawrence S. Brown Jr is also with the Department of Public Health, Weill Medical College, Cornell University, New York. R. Jeffrey Goldsmith is with the Department of Psychiatry, Cincinnati VA Medical Center, University of Cincinnati, Cincinnati, OH. Edmund J. Bini is with the Department of Gastroenterology, VA New York Harbor... |
| ORCID | 0000-0002-7114-7566 |
| VERIFICADO | Sí |
| TOTAL DE OBRAS | 4 |
| TOTAL DE CITAS | 1 |
| TOTAL COMO AUTOR | 4 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2008 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2026 |
| ÍNDICE H | 1 |
Patient Characteristics Associated with Successful Initiation of Extended-Release Naltrexone in the X
BACKGROUND AND AIM: Extended-release injectable naltrexone (XR-Naltrexone) is an effective treatment for opioid use disorder (OUD); however, initiation can be challenging as it requires an opioid-free period. This exploratory analysis examines patient characteristics associated with successful initiation of XR-Naltrexone in the National Drug Abuse Treatment Clinical Trials Network (CTN-0051) Extended-Release Naltrexone versus Buprenorphine for Op…
Patient Characteristics Associated with Opioid Abstinence after Participation in a Trial of Buprenorphine versus Injectable Naltrexone
Background and Objectives: Better understanding of predictors of opioid abstinence among patients with opioid use disorder (OUD) may help to inform interventions and personalize treatment plans. This analysis examined patient characteristics associated with opioid abstinence in the X:BOT (Extended-Release Naltrexone versus Buprenorphine for Opioid Treatment) trial. Methods: This post-hoc analysis examined factors associated with past-month opioid…
High incidence of PTSD diagnosis and trauma-related symptoms in a trauma exposed bipolar I and II sample
Trauma load in BD is marked with a lack of difference in trauma profile between BD-I and BD-II. Although PTSD and sexual abuse may have a negative impact on BD course, in many indicators of BD severity there is no significant difference between PTSD and subsyndromal trauma symptoms. Our results support further research to clarify the role of subsyndromic PTSD symptoms, and highlight the importance of screening for trauma in BD patients
States and Substance Abuse Treatment Programs
Community-based substance abuse treatment programs provide HIV, hepatitis C virus, and sexually transmitted infection services. To explore how state funding and guidelines affect practice, we surveyed state agency administrators and substance abuse treatment program administrators and clinicians regarding 8 infection-related services. Although state funding for infection-related services is widely available, substance abuse treatment programs do …
States and Substance Abuse Treatment Programs
Community-based substance abuse treatment programs provide HIV, hepatitis C virus, and sexually transmitted infection services. To explore how state funding and guidelines affect practice, we surveyed state agency administrators and substance abuse treatment program administrators and clinicians regarding 8 infection-related services. Although state funding for infection-related services is widely available, substance abuse treatment programs do …
States and Substance Abuse Treatment Programs
Community-based substance abuse treatment programs provide HIV, hepatitis C virus, and sexually transmitted infection services. To explore how state funding and guidelines affect practice, we surveyed state agency administrators and substance abuse treatment program administrators and clinicians regarding 8 infection-related services. Although state funding for infection-related services is widely available, substance abuse treatment programs do …
Patient Characteristics Associated with Opioid Abstinence after Participation in a Trial of Buprenorphine versus Injectable Naltrexone
Background and Objectives: Better understanding of predictors of opioid abstinence among patients with opioid use disorder (OUD) may help to inform interventions and personalize treatment plans. This analysis examined patient characteristics associated with opioid abstinence in the X:BOT (Extended-Release Naltrexone versus Buprenorphine for Opioid Treatment) trial. Methods: This post-hoc analysis examined factors associated with past-month opioid…
High incidence of PTSD diagnosis and trauma-related symptoms in a trauma exposed bipolar I and II sample
Trauma load in BD is marked with a lack of difference in trauma profile between BD-I and BD-II. Although PTSD and sexual abuse may have a negative impact on BD course, in many indicators of BD severity there is no significant difference between PTSD and subsyndromal trauma symptoms. Our results support further research to clarify the role of subsyndromic PTSD symptoms, and highlight the importance of screening for trauma in BD patients
Patient Characteristics Associated with Successful Initiation of Extended-Release Naltrexone in the X
BACKGROUND AND AIM: Extended-release injectable naltrexone (XR-Naltrexone) is an effective treatment for opioid use disorder (OUD); however, initiation can be challenging as it requires an opioid-free period. This exploratory analysis examines patient characteristics associated with successful initiation of XR-Naltrexone in the National Drug Abuse Treatment Clinical Trials Network (CTN-0051) Extended-Release Naltrexone versus Buprenorphine for Op…
Medicine (3 obras) · Psychiatry (3 obras) · Substance Abuse Treatment and Outcomes (3 obras) · Internal Medicine (2 obras) · Naltrexone (2 obras) · Opioid Use Disorder Treatment (2 obras) · Prenatal Substance Exposure Effects (2 obras) · Abstinence (1 obras) · Agency (philosophy) (1 obras) · Bipolar Disorder and Treatment (1 obras)